These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35997337)
1. Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Mancini F; Micoli F; Rossi O BioTech (Basel); 2022 Jul; 11(3):. PubMed ID: 35997337 [TBL] [Abstract][Full Text] [Related]
2. Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Rossi O; Molesti E; Saul A; Giannelli C; Micoli F; Necchi F High Throughput; 2020 Jun; 9(2):. PubMed ID: 32521658 [TBL] [Abstract][Full Text] [Related]
3. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979 [No Abstract] [Full Text] [Related]
6. Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal Aruta MG; De Simone D; Dale H; Chirwa E; Kadwala I; Mbewe M; Banda H; Gordon M; Pizza M; Berlanda Scorza F; Nyirenda T; Canals R; Rossi O; On Behalf Of The Vacc-iNTS Consortium Collaborators Methods Protoc; 2022 Dec; 5(6):. PubMed ID: 36548142 [No Abstract] [Full Text] [Related]
7. Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production. Lin J; Smith MA; Benjamin WH; Kaminski RW; Wenzel H; Nahm MH Clin Vaccine Immunol; 2016 Aug; 23(8):681-8. PubMed ID: 27280622 [TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout. Necchi F; Saul A; Rondini S PLoS One; 2017; 12(2):e0172163. PubMed ID: 28192483 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Oaks EV; Turbyfill KR Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513 [TBL] [Abstract][Full Text] [Related]
10. Outer Membrane Vesicles Derived from Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809 [TBL] [Abstract][Full Text] [Related]
11. Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study. Shimanovich AA; Buskirk AD; Heine SJ; Blackwelder WC; Wahid R; Kotloff KL; Pasetti MF Clin Vaccine Immunol; 2017 Feb; 24(2):. PubMed ID: 27927680 [TBL] [Abstract][Full Text] [Related]
12. Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis. Ndungo E; Andronescu LR; Buchwald AG; Lemme-Dumit JM; Mawindo P; Kapoor N; Fairman J; Laufer MK; Pasetti MF Front Immunol; 2021; 12():725129. PubMed ID: 34721387 [No Abstract] [Full Text] [Related]
13. Setup of luminescence-based serum bactericidal assay against Salmonella Paratyphi A. Necchi F; Saul A; Rondini S J Immunol Methods; 2018 Oct; 461():117-121. PubMed ID: 29969587 [TBL] [Abstract][Full Text] [Related]
15. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a. Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309 [TBL] [Abstract][Full Text] [Related]
16. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes. Citiulo F; Necchi F; Mancini F; Rossi O; Aruta MG; Gasperini G; Alfini R; Rondini S; Micoli F; Rappuoli R; Saul A; Martin LB PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009826. PubMed ID: 34644291 [TBL] [Abstract][Full Text] [Related]
17. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Raso MM; Gasperini G; Alfini R; Schiavo F; Aruta MG; Carducci M; Forgione MC; Martini S; Cescutti P; Necchi F; Micoli F Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260067 [No Abstract] [Full Text] [Related]
20. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]